Clinical trial
Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter
NCT07296328 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- January 15, 2026
- Completion date
- April 1, 2027
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.